14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $2.30 $2.95 Wednesday, 24th Apr 2024 CLLS stock ended at $2.50. This is 4.57% less than the trading day before Tuesday, 23rd Apr 2024. During the day the stock fluctuated 3.63% from a day low at $2.48 to a day high of $2.57.
90 days $2.30 $3.13
52 weeks $0.96 $3.77

Historical Cellectis S.A. prices

Date Open High Low Close Volume
Dec 04, 2020 $27.59 $29.85 $27.59 $29.44 355 490
Dec 03, 2020 $27.70 $29.53 $27.41 $29.20 390 551
Dec 02, 2020 $25.36 $26.66 $25.02 $26.58 173 144
Dec 01, 2020 $25.80 $27.96 $25.78 $26.84 354 243
Nov 30, 2020 $24.50 $25.37 $23.78 $25.37 145 517
Nov 27, 2020 $23.18 $24.23 $22.91 $24.21 111 042
Nov 25, 2020 $22.12 $22.45 $21.80 $22.42 103 838
Nov 24, 2020 $21.83 $23.25 $21.71 $22.56 135 203
Nov 23, 2020 $21.68 $22.46 $21.26 $22.11 128 213
Nov 20, 2020 $21.76 $21.76 $20.55 $21.15 141 046
Nov 19, 2020 $20.73 $22.19 $20.71 $22.10 214 861
Nov 18, 2020 $20.29 $21.22 $20.17 $21.02 198 567
Nov 17, 2020 $19.44 $20.12 $19.16 $19.70 122 139
Nov 16, 2020 $19.27 $20.08 $19.13 $20.06 208 106
Nov 13, 2020 $18.30 $19.25 $18.24 $19.12 166 908
Nov 12, 2020 $17.65 $18.07 $17.31 $17.99 108 446
Nov 11, 2020 $17.51 $17.90 $17.12 $17.61 133 260
Nov 10, 2020 $17.62 $18.20 $16.93 $16.98 132 063
Nov 09, 2020 $17.20 $18.32 $17.01 $17.90 202 840
Nov 06, 2020 $17.06 $17.75 $16.76 $17.06 183 139
Nov 05, 2020 $17.38 $18.13 $16.97 $18.13 336 903
Nov 04, 2020 $16.45 $16.94 $16.06 $16.50 204 685
Nov 03, 2020 $16.53 $16.68 $15.80 $15.89 187 632
Nov 02, 2020 $16.78 $16.81 $15.25 $15.87 331 570
Oct 30, 2020 $16.37 $16.46 $15.62 $15.91 159 299
Click to get the best stock tips daily for free!

About Cellectis S.A.

Cellectis S.A. Cellectis S.A., a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. It operates through two segments, Therapeutics and Plants. The company is developing UCART19, an allogeneic T-cell product candidate for the treatment of CD19-expressing hematologic malignancies, such as acute lymphoblastic leukemia; ALLO-501 and ALL... CLLS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT